BiotechTube
Home/SyntIV/Alon Herschhorn, Ph.D.
AH

Alon Herschhorn, Ph.D.

Founder and Chief Executive of Operations

SyntIV

Therapeutic Areas

OncologyInfectious Diseases

SyntIV Pipeline

DrugIndicationPhase
Synthetic Penetrating AntibodiesViral infections, CancerPre-clinical
TCR-Mimic Antibodies & CARsCancer, Viral infectionsPre-clinical